Literature DB >> 30501992

Increased mcr-1 in pathogenic Escherichia coli from diseased swine, Taiwan.

Jing-Yi Liu1, Tsai-Lien Liao2, Wei-Cheng Huang3, Yen-Ming Liu2, Keh-Ming Wu4, Tsai-Ling Lauderdale3, Shih-Feng Tsai2, Shu-Chen Kuo5, Hung-Chih Kuo6.   

Abstract

PURPOSE: To investigate the increasing prevalence of colistin resistance in animal Escherichia coli isolates and their mcr-1-carrying plasmids, especially those shared by isolates from human and retail meats.
METHODS: E. coli from diseased swine and poultry recovered between 2012 and 2016 were studied. Susceptibility was determined using broth microdilution method or Vitek II system. Fifty-eight mcr-1-positive isolates were randomly selected for further testing, including pulsed-field gel electrophoresis (PFGE) for clonality determination, S1- or I-CeuI-PFGE and Southern blotting for localization of mcr-1, and conjugation for transmissibility. Whole genome sequencing (WGS) was performed for the genetic structure of plasmids.
RESULTS: Among the 1234 E. coli isolates from diseased swine, colistin resistance increased from 14.6% (14/96) in 2012 to 43.8% (63/144) in 2016 with a paralleled increase in mcr-1-positivity from 12.5% (12/96) to 33.3% (48/144) in 2016 (P < 0.001), but no such significant increase was observed in the 489 diseased poultry isolates. The 58 clonally diverse isolates were resistant to multiple antibiotics commonly used in humans. PFGE and Southern blotting revealed one chromosome-located mcr-1 and various mcr-1-borne plasmids, all of which were transferable to E. coli J53. WGS revealed that the prevalent 60-kb and 30-kb plasmid was the same as pHNSHP45 in China and pESTMCR in Estonia, respectively, which were both present in human isolates in Taiwan.
CONCLUSION: Increased colistin resistance and mcr-1-positivity in diseased swine isolates and detection of mcr-1 carried on similar plasmids in isolates from animals and humans stress the need to monitor resistance in both sectors.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Colistin resistance; Escherichia coli; Swine; mcr-1

Mesh:

Substances:

Year:  2018        PMID: 30501992     DOI: 10.1016/j.jmii.2018.10.011

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  5 in total

1.  Prevalence, Characteristics, and Clonal Distribution of Escherichia coli Carrying Mobilized Colistin Resistance Gene mcr-1.1 in Swine Farms and Their Differences According to Swine Production Stages.

Authors:  Soomin Lee; Jae-Uk An; JungHa Woo; Hyokeun Song; Saehah Yi; Woo-Hyun Kim; Ju-Hoon Lee; Sangryeol Ryu; Seongbeom Cho
Journal:  Front Microbiol       Date:  2022-05-06       Impact factor: 6.064

2.  High Prevalence of Colistin-Resistant Escherichia coli with Chromosomally Carried mcr-1 in Healthy Residents in Vietnam.

Authors:  Takahiro Yamaguchi; Ryuji Kawahara; Kouta Hamamoto; Itaru Hirai; Diep Thi Khong; Thang Nam Nguyen; Hoa Thi Tran; Daisuke Motooka; Shota Nakamura; Yoshimasa Yamamoto
Journal:  mSphere       Date:  2020-03-04       Impact factor: 4.389

3.  Antimicrobial Resistance of Non-O157 Shiga Toxin-Producing Escherichia coli Isolated from Humans and Domestic Animals.

Authors:  Yanyu Pan; Bin Hu; Xiangning Bai; Xi Yang; Lijiao Cao; Qian Liu; Hui Sun; Juan Li; Ji Zhang; Dong Jin; Yanwen Xiong
Journal:  Antibiotics (Basel)       Date:  2021-01-14

Review 4.  Worldwide Prevalence of mcr-mediated Colistin-Resistance Escherichia coli in Isolates of Clinical Samples, Healthy Humans, and Livestock-A Systematic Review and Meta-Analysis.

Authors:  Carlos Bastidas-Caldes; Jacobus H de Waard; María Soledad Salgado; María José Villacís; Marco Coral-Almeida; Yoshimasa Yamamoto; Manuel Calvopiña
Journal:  Pathogens       Date:  2022-06-08

5.  A Large Spatial Survey of Colistin-Resistant Gene mcr-1-Carrying E. coli in Rivers across Taiwan.

Authors:  Ching-Hao Teng; Pin-Chieh Wu; Sen-Lin Tang; Yi-Chen Chen; Ming-Fang Cheng; Ping-Chih Huang; Wen-Chien Ko; Jiun-Ling Wang
Journal:  Microorganisms       Date:  2021-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.